APO Research
Talk to an analyst

APO RESEARCH · REPORT

Rare Disease Therapy Solutions

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Rare Disease Therapy Solutions Industry Growth and Trends Forecast to 2032

4 January 2026114 pages

Choose your research edition.

Industry ResearchRare Disease Therapy Solutions Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Rare Disease Therapy Solutions Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Rare Disease Therapy Solutions Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rare Disease Therapy Solutions Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Rare Disease Therapy Solutions Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

According to APO Research, the global Rare Disease Therapy Solutions market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Rare Disease Therapy Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Rare Disease Therapy Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Rare Disease Therapy Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Rare Disease Therapy Solutions market include Sarepta, Ultragenyx, Amicus Therapeutics, AOP Health, Fortrea, Chiesi Global Rare Diseases, Travere Therapeutics, Sobi and Novartis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Rare Disease Therapy Solutions market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Rare Disease Therapy Solutions market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Rare Disease Therapy Solutions market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Rare Disease Therapy Solutions.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Rare Disease Therapy Solutions market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Rare Disease Therapy Solutions Market by Company

Sarepta

Ultragenyx

Amicus Therapeutics

AOP Health

Fortrea

Chiesi Global Rare Diseases

Travere Therapeutics

Sobi

Novartis

Vertex Pharmaceuticals

Sarepta International UK Ltd.

Orsini

Roche

Certara

Sciensus

Rare Disease Therapy Solutions Segment by Type

Gene Therapy

Enzyme Replacement Therapy

Small Molecule Targeted Drugs

Cell Therapy

Others

Rare Disease Therapy Solutions Segment by Application

Metabolic Diseases

Hematological Diseases

Others

Rare Disease Therapy Solutions Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rare Disease Therapy Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rare Disease Therapy Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rare Disease Therapy Solutions.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Rare Disease Therapy Solutions companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Rare Disease Therapy Solutions Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Rare Disease Therapy Solutions Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Rare Disease Therapy Solutions Market Share by Region (2021-2026) Table 4. Global Rare Disease Therapy Solutions Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Rare Disease Therapy Solutions Market Share by Region (2027-2032) Table 6. Global Rare Disease Therapy Solutions Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Rare Disease Therapy Solutions Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Rare Disease Therapy Solutions Market Size Share by Type (2021-2026) Table 9. Global Rare Disease Therapy Solutions Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Rare Disease Therapy Solutions Market Size Share Forecasted by Type (2027-2032) Table 11. North America Rare Disease Therapy Solutions Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Rare Disease Therapy Solutions Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Rare Disease Therapy Solutions Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Rare Disease Therapy Solutions Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Rare Disease Therapy Solutions Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Rare Disease Therapy Solutions Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Rare Disease Therapy Solutions Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Rare Disease Therapy Solutions Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Rare Disease Therapy Solutions Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Rare Disease Therapy Solutions Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Rare Disease Therapy Solutions Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Rare Disease Therapy Solutions Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Rare Disease Therapy Solutions Market Size Share by Application (2021-2026) Table 24. Global Rare Disease Therapy Solutions Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Rare Disease Therapy Solutions Market Size Share Forecasted by Application (2027-2032) Table 26. North America Rare Disease Therapy Solutions Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Rare Disease Therapy Solutions Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Rare Disease Therapy Solutions Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Rare Disease Therapy Solutions Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Rare Disease Therapy Solutions Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Rare Disease Therapy Solutions Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Rare Disease Therapy Solutions Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Rare Disease Therapy Solutions Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Rare Disease Therapy Solutions Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Rare Disease Therapy Solutions Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Rare Disease Therapy Solutions Industry Trends Table 37. Rare Disease Therapy Solutions Industry Drivers Table 38. Rare Disease Therapy Solutions Industry Opportunities and Challenges Table 39. Rare Disease Therapy Solutions Industry Restraints Table 40. Global Rare Disease Therapy Solutions Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Rare Disease Therapy Solutions Revenue Market Share by Company (2021-2026) Table 42. Global Rare Disease Therapy Solutions Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Rare Disease Therapy Solutions Key Company Headquarters & Area Served Table 44. Global Rare Disease Therapy Solutions Company, Product Type & Application Table 45. Global Rare Disease Therapy Solutions Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Rare Disease Therapy Solutions by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Sarepta Company Information Table 49. Sarepta Business Overview Table 50. Sarepta Rare Disease Therapy Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Sarepta Rare Disease Therapy Solutions Product Portfolio Table 52. Sarepta Recent Development Table 53. Ultragenyx Company Information Table 54. Ultragenyx Business Overview Table 55. Ultragenyx Rare Disease Therapy Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Ultragenyx Rare Disease Therapy Solutions Product Portfolio Table 57. Ultragenyx Recent Development Table 58. Amicus Therapeutics Company Information Table 59. Amicus Therapeutics Business Overview Table 60. Amicus Therapeutics Rare Disease Therapy Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Amicus Therapeutics Rare Disease Therapy Solutions Product Portfolio Table 62. Amicus Therapeutics Recent Development Table 63. AOP Health Company Information Table 64. AOP Health Business Overview Table 65. AOP Health Rare Disease Therapy Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. AOP Health Rare Disease Therapy Solutions Product Portfolio Table 67. AOP Health Recent Development Table 68. Fortrea Company Information Table 69. Fortrea Business Overview Table 70. Fortrea Rare Disease Therapy Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Fortrea Rare Disease Therapy Solutions Product Portfolio Table 72. Fortrea Recent Development Table 73. Chiesi Global Rare Diseases Company Information Table 74. Chiesi Global Rare Diseases Business Overview Table 75. Chiesi Global Rare Diseases Rare Disease Therapy Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Chiesi Global Rare Diseases Rare Disease Therapy Solutions Product Portfolio Table 77. Chiesi Global Rare Diseases Recent Development Table 78. Travere Therapeutics Company Information Table 79. Travere Therapeutics Business Overview Table 80. Travere Therapeutics Rare Disease Therapy Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Travere Therapeutics Rare Disease Therapy Solutions Product Portfolio Table 82. Travere Therapeutics Recent Development Table 83. Sobi Company Information Table 84. Sobi Business Overview Table 85. Sobi Rare Disease Therapy Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Sobi Rare Disease Therapy Solutions Product Portfolio Table 87. Sobi Recent Development Table 88. Novartis Company Information Table 89. Novartis Business Overview Table 90. Novartis Rare Disease Therapy Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Novartis Rare Disease Therapy Solutions Product Portfolio Table 92. Novartis Recent Development Table 93. Vertex Pharmaceuticals Company Information Table 94. Vertex Pharmaceuticals Business Overview Table 95. Vertex Pharmaceuticals Rare Disease Therapy Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Vertex Pharmaceuticals Rare Disease Therapy Solutions Product Portfolio Table 97. Vertex Pharmaceuticals Recent Development Table 98. Sarepta International UK Ltd. Company Information Table 99. Sarepta International UK Ltd. Business Overview Table 100. Sarepta International UK Ltd. Rare Disease Therapy Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Sarepta International UK Ltd. Rare Disease Therapy Solutions Product Portfolio Table 102. Sarepta International UK Ltd. Recent Development Table 103. Orsini Company Information Table 104. Orsini Business Overview Table 105. Orsini Rare Disease Therapy Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Orsini Rare Disease Therapy Solutions Product Portfolio Table 107. Orsini Recent Development Table 108. Roche Company Information Table 109. Roche Business Overview Table 110. Roche Rare Disease Therapy Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Roche Rare Disease Therapy Solutions Product Portfolio Table 112. Roche Recent Development Table 113. Certara Company Information Table 114. Certara Business Overview Table 115. Certara Rare Disease Therapy Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Certara Rare Disease Therapy Solutions Product Portfolio Table 117. Certara Recent Development Table 118. Sciensus Company Information Table 119. Sciensus Business Overview Table 120. Sciensus Rare Disease Therapy Solutions Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Sciensus Rare Disease Therapy Solutions Product Portfolio Table 122. Sciensus Recent Development Table 123. North America Rare Disease Therapy Solutions Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Rare Disease Therapy Solutions Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Rare Disease Therapy Solutions Market Share by Country (2021-2026) Table 126. North America Rare Disease Therapy Solutions Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Rare Disease Therapy Solutions Market Share Forecast by Country (2027-2032) Table 128. Europe Rare Disease Therapy Solutions Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe Rare Disease Therapy Solutions Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe Rare Disease Therapy Solutions Market Share by Country (2021-2026) Table 131. Europe Rare Disease Therapy Solutions Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe Rare Disease Therapy Solutions Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Rare Disease Therapy Solutions Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Rare Disease Therapy Solutions Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific Rare Disease Therapy Solutions Market Share by Country (2021-2026) Table 136. Asia-Pacific Rare Disease Therapy Solutions Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific Rare Disease Therapy Solutions Market Share Forecast by Country (2027-2032) Table 138. Latin America Rare Disease Therapy Solutions Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America Rare Disease Therapy Solutions Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America Rare Disease Therapy Solutions Market Share by Country (2021-2026) Table 141. Latin America Rare Disease Therapy Solutions Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America Rare Disease Therapy Solutions Market Share Forecast by Country (2027-2032) Table 143. Middle East & Africa Rare Disease Therapy Solutions Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East & Africa Rare Disease Therapy Solutions Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East & Africa Rare Disease Therapy Solutions Market Share by Country (2021-2026) Table 146. Middle East & Africa Rare Disease Therapy Solutions Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East & Africa Rare Disease Therapy Solutions Market Share Forecast by Country (2027-2032) Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Rare Disease Therapy Solutions Product Image Figure 3. Global Rare Disease Therapy Solutions Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Rare Disease Therapy Solutions Market Size (2021-2032) & (US$ Million) Figure 5. Global Rare Disease Therapy Solutions Market Share by Region: 2025 VS 2032 Figure 6. Global Rare Disease Therapy Solutions Market Share by Region (2021-2032) Figure 7. North America Rare Disease Therapy Solutions Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Rare Disease Therapy Solutions Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Rare Disease Therapy Solutions Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Rare Disease Therapy Solutions Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Rare Disease Therapy Solutions Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Gene Therapy Image Figure 13. Global Gene Therapy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Enzyme Replacement Therapy Image Figure 15. Global Enzyme Replacement Therapy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Small Molecule Targeted Drugs Image Figure 17. Global Small Molecule Targeted Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Cell Therapy Image Figure 19. Global Cell Therapy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Others Image Figure 21. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Global Rare Disease Therapy Solutions Market Size Overview by Type (2021-2032) & (US$ Million) Figure 23. Global Rare Disease Therapy Solutions Market Share by Type 2025 VS 2032 Figure 24. North America Rare Disease Therapy Solutions Market Size Share by Type (2021-2032) Figure 25. Europe Rare Disease Therapy Solutions Market Size Share by Type (2021-2032) Figure 26. Asia-Pacific Rare Disease Therapy Solutions Market Size Share by Type (2021-2032) Figure 27. Latin America Rare Disease Therapy Solutions Market Size Share by Type (2021-2032) Figure 28. Middle East and Africa Rare Disease Therapy Solutions Market Size Share by Type (2021-2032) Figure 29. Metabolic Diseases Image Figure 30. Global Metabolic Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Hematological Diseases Image Figure 32. Global Hematological Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Others Image Figure 34. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Rare Disease Therapy Solutions Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Rare Disease Therapy Solutions Market Share by Application 2025 VS 2032 Figure 37. North America Rare Disease Therapy Solutions Market Size Share by Application (2021-2032) Figure 38. Europe Rare Disease Therapy Solutions Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Rare Disease Therapy Solutions Market Size Share by Application (2021-2032) Figure 40. Latin America Rare Disease Therapy Solutions Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Rare Disease Therapy Solutions Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Rare Disease Therapy Solutions Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Rare Disease Therapy Solutions Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Rare Disease Therapy Solutions Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Rare Disease Therapy Solutions Market Share by Country (2021-2032) Figure 47. Europe Rare Disease Therapy Solutions Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Rare Disease Therapy Solutions Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Rare Disease Therapy Solutions Market Share by Country (2021-2032) Figure 50. Asia-Pacific Rare Disease Therapy Solutions Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Rare Disease Therapy Solutions Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Rare Disease Therapy Solutions Market Share by Country (2021-2032) Figure 53. Latin America Rare Disease Therapy Solutions Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Rare Disease Therapy Solutions Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Rare Disease Therapy Solutions Market Share by Country (2021-2032) Figure 56. Middle East & Africa Rare Disease Therapy Solutions Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Rare Disease Therapy Solutions Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Rare Disease Therapy Solutions Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Gene Therapy
  • Enzyme Replacement Therapy
  • Small Molecule Targeted Drugs
  • Cell Therapy
  • Others
Applications
  • Metabolic Diseases
  • Hematological Diseases
  • Others
Companies covered
  • Sarepta
  • Ultragenyx
  • Amicus Therapeutics
  • AOP Health
  • Fortrea
  • Chiesi Global Rare Diseases
  • Travere Therapeutics
  • Sobi
  • Novartis
  • Vertex Pharmaceuticals
  • Sarepta International UK Ltd.
  • Orsini
  • Roche
  • Certara
  • Sciensus

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Rare Disease Therapy Solutions Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Rare Disease Therapy Solutions Market Size by Region (2021-2032)
  5. 1.4.1 Global Rare Disease Therapy Solutions Market Size by Region (2021-2026)
  6. 1.4.2 Global Rare Disease Therapy Solutions Market Size by Region (2027-2032)
  7. 1.5 Key Regions Rare Disease Therapy Solutions Market Size (2021-2032)
  8. 1.5.1 North America Rare Disease Therapy Solutions Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Rare Disease Therapy Solutions Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Rare Disease Therapy Solutions Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Rare Disease Therapy Solutions Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Rare Disease Therapy Solutions Market Size Growth Rate (2021-2032)
2 Rare Disease Therapy Solutions Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Gene Therapy
  3. 2.1.2 Enzyme Replacement Therapy
  4. 2.1.3 Small Molecule Targeted Drugs
  5. 2.1.4 Cell Therapy
  6. 2.1.5 Others
  7. 2.2 Global Rare Disease Therapy Solutions Market Size by Type
  8. 2.2.1 Global Rare Disease Therapy Solutions Market Size Overview by Type (2021-2032)
  9. 2.2.2 Global Rare Disease Therapy Solutions Historic Market Size Review by Type (2021-2026)
  10. 2.2.3 Global Rare Disease Therapy Solutions Market Size Forecasted by Type (2027-2032)
  11. 2.3 Global Rare Disease Therapy Solutions Market Size by Regions
  12. 2.3.1 North America Rare Disease Therapy Solutions Market Size Breakdown by Type (2021-2026)
  13. 2.3.2 Europe Rare Disease Therapy Solutions Market Size Breakdown by Type (2021-2026)
  14. 2.3.3 Asia-Pacific Rare Disease Therapy Solutions Market Size Breakdown by Type (2021-2026)
  15. 2.3.4 South America Rare Disease Therapy Solutions Market Size Breakdown by Type (2021-2026)
  16. 2.3.5 Middle East and Africa Rare Disease Therapy Solutions Market Size Breakdown by Type (2021-2026)
3 Rare Disease Therapy Solutions Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Metabolic Diseases
  3. 3.1.2 Hematological Diseases
  4. 3.1.3 Others
  5. 3.2 Global Rare Disease Therapy Solutions Market Size by Application
  6. 3.2.1 Global Rare Disease Therapy Solutions Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Rare Disease Therapy Solutions Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Rare Disease Therapy Solutions Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Rare Disease Therapy Solutions Market Size by Regions
  10. 3.3.1 North America Rare Disease Therapy Solutions Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Rare Disease Therapy Solutions Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Rare Disease Therapy Solutions Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Rare Disease Therapy Solutions Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Rare Disease Therapy Solutions Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Rare Disease Therapy Solutions Industry Trends
  2. 4.2 Rare Disease Therapy Solutions Industry Drivers
  3. 4.3 Rare Disease Therapy Solutions Industry Opportunities and Challenges
  4. 4.4 Rare Disease Therapy Solutions Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Rare Disease Therapy Solutions Revenue (2021-2026)
  2. 5.2 Global Rare Disease Therapy Solutions Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Rare Disease Therapy Solutions Key Company Headquarters & Area Served
  4. 5.4 Global Rare Disease Therapy Solutions Company, Product Type & Application
  5. 5.5 Global Rare Disease Therapy Solutions Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Rare Disease Therapy Solutions Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Rare Disease Therapy Solutions Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Rare Disease Therapy Solutions Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Sarepta
  2. 6.1.1 Sarepta Company Information
  3. 6.1.2 Sarepta Business Overview
  4. 6.1.3 Sarepta Rare Disease Therapy Solutions Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Sarepta Rare Disease Therapy Solutions Product Portfolio
  6. 6.1.5 Sarepta Recent Developments
  7. 6.2 Ultragenyx
  8. 6.2.1 Ultragenyx Company Information
  9. 6.2.2 Ultragenyx Business Overview
  10. 6.2.3 Ultragenyx Rare Disease Therapy Solutions Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Ultragenyx Rare Disease Therapy Solutions Product Portfolio
  12. 6.2.5 Ultragenyx Recent Developments
  13. 6.3 Amicus Therapeutics
  14. 6.3.1 Amicus Therapeutics Company Information
  15. 6.3.2 Amicus Therapeutics Business Overview
  16. 6.3.3 Amicus Therapeutics Rare Disease Therapy Solutions Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Amicus Therapeutics Rare Disease Therapy Solutions Product Portfolio
  18. 6.3.5 Amicus Therapeutics Recent Developments
  19. 6.4 AOP Health
  20. 6.4.1 AOP Health Company Information
  21. 6.4.2 AOP Health Business Overview
  22. 6.4.3 AOP Health Rare Disease Therapy Solutions Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 AOP Health Rare Disease Therapy Solutions Product Portfolio
  24. 6.4.5 AOP Health Recent Developments
  25. 6.5 Fortrea
  26. 6.5.1 Fortrea Company Information
  27. 6.5.2 Fortrea Business Overview
  28. 6.5.3 Fortrea Rare Disease Therapy Solutions Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Fortrea Rare Disease Therapy Solutions Product Portfolio
  30. 6.5.5 Fortrea Recent Developments
  31. 6.6 Chiesi Global Rare Diseases
  32. 6.6.1 Chiesi Global Rare Diseases Company Information
  33. 6.6.2 Chiesi Global Rare Diseases Business Overview
  34. 6.6.3 Chiesi Global Rare Diseases Rare Disease Therapy Solutions Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Chiesi Global Rare Diseases Rare Disease Therapy Solutions Product Portfolio
  36. 6.6.5 Chiesi Global Rare Diseases Recent Developments
  37. 6.7 Travere Therapeutics
  38. 6.7.1 Travere Therapeutics Company Information
  39. 6.7.2 Travere Therapeutics Business Overview
  40. 6.7.3 Travere Therapeutics Rare Disease Therapy Solutions Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Travere Therapeutics Rare Disease Therapy Solutions Product Portfolio
  42. 6.7.5 Travere Therapeutics Recent Developments
  43. 6.8 Sobi
  44. 6.8.1 Sobi Company Information
  45. 6.8.2 Sobi Business Overview
  46. 6.8.3 Sobi Rare Disease Therapy Solutions Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Sobi Rare Disease Therapy Solutions Product Portfolio
  48. 6.8.5 Sobi Recent Developments
  49. 6.9 Novartis
  50. 6.9.1 Novartis Company Information
  51. 6.9.2 Novartis Business Overview
  52. 6.9.3 Novartis Rare Disease Therapy Solutions Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Novartis Rare Disease Therapy Solutions Product Portfolio
  54. 6.9.5 Novartis Recent Developments
  55. 6.10 Vertex Pharmaceuticals
  56. 6.10.1 Vertex Pharmaceuticals Company Information
  57. 6.10.2 Vertex Pharmaceuticals Business Overview
  58. 6.10.3 Vertex Pharmaceuticals Rare Disease Therapy Solutions Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Vertex Pharmaceuticals Rare Disease Therapy Solutions Product Portfolio
  60. 6.10.5 Vertex Pharmaceuticals Recent Developments
  61. 6.11 Sarepta International UK Ltd.
  62. 6.11.1 Sarepta International UK Ltd. Company Information
  63. 6.11.2 Sarepta International UK Ltd. Business Overview
  64. 6.11.3 Sarepta International UK Ltd. Rare Disease Therapy Solutions Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Sarepta International UK Ltd. Rare Disease Therapy Solutions Product Portfolio
  66. 6.11.5 Sarepta International UK Ltd. Recent Developments
  67. 6.12 Orsini
  68. 6.12.1 Orsini Company Information
  69. 6.12.2 Orsini Business Overview
  70. 6.12.3 Orsini Rare Disease Therapy Solutions Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Orsini Rare Disease Therapy Solutions Product Portfolio
  72. 6.12.5 Orsini Recent Developments
  73. 6.13 Roche
  74. 6.13.1 Roche Company Information
  75. 6.13.2 Roche Business Overview
  76. 6.13.3 Roche Rare Disease Therapy Solutions Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Roche Rare Disease Therapy Solutions Product Portfolio
  78. 6.13.5 Roche Recent Developments
  79. 6.14 Certara
  80. 6.14.1 Certara Company Information
  81. 6.14.2 Certara Business Overview
  82. 6.14.3 Certara Rare Disease Therapy Solutions Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Certara Rare Disease Therapy Solutions Product Portfolio
  84. 6.14.5 Certara Recent Developments
  85. 6.15 Sciensus
  86. 6.15.1 Sciensus Company Information
  87. 6.15.2 Sciensus Business Overview
  88. 6.15.3 Sciensus Rare Disease Therapy Solutions Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Sciensus Rare Disease Therapy Solutions Product Portfolio
  90. 6.15.5 Sciensus Recent Developments
7 North America
  1. 7.1 North America Rare Disease Therapy Solutions Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Rare Disease Therapy Solutions Market Size by Country (2021-2026)
  3. 7.3 North America Rare Disease Therapy Solutions Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Rare Disease Therapy Solutions Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Rare Disease Therapy Solutions Market Size by Country (2021-2026)
  3. 8.3 Europe Rare Disease Therapy Solutions Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Rare Disease Therapy Solutions Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Rare Disease Therapy Solutions Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Rare Disease Therapy Solutions Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Rare Disease Therapy Solutions Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Rare Disease Therapy Solutions Market Size by Country (2021-2026)
  3. 10.3 South America Rare Disease Therapy Solutions Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Rare Disease Therapy Solutions Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Rare Disease Therapy Solutions Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Rare Disease Therapy Solutions Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst